Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.36p
   
  • Change Today:
    -0.080p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 505,970
  • Market Cap: £16.77m
  • RiskGrade: 328
  • Beta: 0.02

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £49,938
Lisa Baderoon 583,963 £19,592
Tim Franklin 525,000 £17,614

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 80,590,404 £2,703,808
Luca & Associates AG 22,000,000 £738,100
Invesco Ltd 17,872,341 £599,617
Aviva Investors Global 11,285,180 £378,618
Alora Pharmaceuticals LLC 10,909,091 £366,000
M&G Investments 7,600,000 £254,980
Prudential plc 7,600,000 £254,980
Capital Income Builder 4,870,367 £163,401
Dr R Zimmer 4,551,553 £152,705
Odey Asset Management 3,433,319 £115,188
Rhone Trustees (Switzerland) SA 3,386,000 £113,600
Pictet Overseas Trust Corporation Limited 3,287,500 £110,296

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 3.36p
Change Today -0.080p
% Change -2.33 %
52 Week High 5.90
52 Week Low 1.09
Volume 505,970
Shares Issued 499.72m
Market Cap £16.77m
Beta 0.02
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.1% below the market average74.1% below the market average74.1% below the market average74.1% below the market average74.1% below the market average
36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average
Price Trend
82.09% above the market average82.09% above the market average82.09% above the market average82.09% above the market average82.09% above the market average
87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 16-May-2025

Time Volume / Share Price
16:28 100 @ 3.11p
16:25 150,000 @ 3.48p
16:17 1,000 @ 3.20p
16:03 10,361 @ 3.20p
15:35 21,628 @ 3.20p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page